2HRA Stock Overview
Engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
H&R GmbH & Co. KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.37 |
| 52 Week High | €5.20 |
| 52 Week Low | €3.23 |
| Beta | 0.84 |
| 1 Month Change | -2.32% |
| 3 Month Change | -10.37% |
| 1 Year Change | -29.79% |
| 3 Year Change | -52.27% |
| 5 Year Change | -31.64% |
| Change since IPO | -54.08% |
Recent News & Updates
Recent updates
This H&R GmbH & Co. KGaA (ETR:2HRA) Analyst Is Way More Bearish Than They Used To Be
Oct 16
Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Have Stalled
Jul 24H&R GmbH KGaA (ETR:2HRA) Is Paying Out A Dividend Of €0.10
Apr 26Why H&R GmbH & Co. KGaA (ETR:2HRA) Could Be Worth Watching
Dec 21Is H&R GmbH KGaA (ETR:2HRA) Using Too Much Debt?
Apr 29H&R GmbH KGaA (ETR:2HRA) Has More To Do To Multiply In Value Going Forward
Aug 09These 4 Measures Indicate That H&R GmbH KGaA (ETR:2HRA) Is Using Debt Extensively
Jul 19H&R GmbH KGaA (ETR:2HRA) Has A Somewhat Strained Balance Sheet
Mar 22What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?
Feb 22H&R GmbH KGaA (ETR:2HRA) Takes On Some Risk With Its Use Of Debt
Nov 27Is H&R GmbH KGaA (ETR:2HRA) A Risky Investment?
Jul 22The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire Confidence
May 26H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value Estimate
Apr 29H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?
Mar 28H&R GmbH KGaA's (ETR:2HRA) Shareholders Are Down 57% On Their Shares
Feb 04
H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?
Dec 13Shareholder Returns
| 2HRA | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -0.3% | -2.9% | -1.1% |
| 1Y | -29.8% | -7.2% | 8.1% |
Return vs Industry: 2HRA underperformed the German Chemicals industry which returned -7.2% over the past year.
Return vs Market: 2HRA underperformed the German Market which returned 8.1% over the past year.
Price Volatility
| 2HRA volatility | |
|---|---|
| 2HRA Average Weekly Movement | 2.8% |
| Chemicals Industry Average Movement | 4.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 2HRA has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2HRA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 1,697 | Niels Hansen | www.hur.com |
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels.
H&R GmbH & Co. KGaA Fundamentals Summary
| 2HRA fundamental statistics | |
|---|---|
| Market cap | €125.44m |
| Earnings (TTM) | €5.53m |
| Revenue (TTM) | €1.34b |
22.7x
P/E Ratio0.1x
P/S RatioIs 2HRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2HRA income statement (TTM) | |
|---|---|
| Revenue | €1.34b |
| Cost of Revenue | €1.04b |
| Gross Profit | €299.56m |
| Other Expenses | €294.03m |
| Earnings | €5.53m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 28, 2025
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 22.36% |
| Net Profit Margin | 0.41% |
| Debt/Equity Ratio | 34.5% |
How did 2HRA perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield66%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 01:56 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
H&R GmbH & Co. KGaA is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Konstantin Wiechert | Baader Helvea Equity Research |
| Knut Woller | Baader Helvea Equity Research |
| Heiko Feber | Bankhaus Lampe KG |